Abstract:FGF21 is a novel secreted protein with robust anti-diabetic, anti-obesity, and anti-atherogenic activities in preclinical species. In the current study, we investigated the signal transduction pathways downstream of FGF21 following acute administration of the growth factor to mice. Focusing on adipose tissues, we identified FGF21-mediated downstream signaling events and target engagement biomarkers. Specifically, RNA profiling of adipose tissues and phosphoproteomic profiling of adipocytes, following FGF21 treatment revealed several specific changes in gene expression and post-translational modifications, specifically phosphorylation, in several relevant proteins. Affymetrix microarray analysis of white adipose tissues isolated from both C57BL/6 (fed either regular chow or HFD) and db/db mice identified over 150 robust potential RNA transcripts and over 50 potential secreted proteins that were changed greater than 1.5 fold by FGF21 acutely. Phosphoprofiling analysis identified over 130 phosphoproteins that were modulated greater than 1.5 fold by FGF21 in 3T3-L1 adipocytes. Bioinformatic analysis of the combined gene and phosphoprotein profiling data identified a number of known metabolic pathways such as glucose uptake, insulin receptor signaling, Erk/Mapk signaling cascades, and lipid metabolism. Moreover, a number of novel events with hitherto unknown links to FGF21 signaling were observed at both the transcription and protein phosphorylation levels following treatment. We conclude that such a combined "omics" approach can be used not only to identify robust biomarkers for novel therapeutics but can also enhance our understanding of downstream signaling pathways; in the example presented here, novel FGF21-mediated signaling events in adipose tissue have been revealed that warrant further investigation.

Fgf6 Promotes Adipocyte Progenitor Cell Proliferation for Adipose Tissue Homeostasis

Fibroblast growth factor 6 promotes adipocyte progenitor cell proliferation for adipose tissue homeostasis

FGF2 disruption enhances thermogenesis in brown and beige fat to protect against adiposity and hepatic steatosis

FGF2 disruption enhances thermogenesis in brown and beige fat to protect against obesity and hepatic steatosis

Fibroblast Growth Factor-21 Maintains Glucose Homeostasis Through Influencing the Expansion and Function of Subcutaneous Adipose Tissue

Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A

FGF1 ameliorates obesity-associated hepatic steatosis by reversing IGFBP2 hypermethylation

FGF9 inhibits browning program of white adipocytes and associates with human obesity.

Skeletal muscle–targeted delivery of Fgf6 protects mice from diet-induced obesity and insulin resistance

[Fibroblast Growth Factor-1 Inhibits Wnt/β-catenin Pathway During Adipogenesis].

Targeted Overexpression of Inducible 6-Phosphofructo-2-kinase in Adipose Tissue Increases Fat Deposition but Protects against Diet-induced Insulin Resistance and Inflammatory Responses

GDF5 Promotes White Adipose Tissue Thermogenesis Via P38 MAPK Signaling Pathway

FGF21 promotes thermogenic gene expression as an autocrine factor in adipocytes

Fibroblast growth factor-1 (FGF-1) promotes adipogenesis by downregulation of carboxypeptidase A4 (CPA4) – a negative regulator of adipogenesis implicated in the modulation of local and systemic insulin sensitivity

Fibroblast Growth Factor 21 Increases Insulin Sensitivity Through Specific Expansion of Subcutaneous Fat

FSP1-positive Fibroblasts Are Adipogenic Niche and Regulate Adipose Homeostasis

FGF signaling promotes spreading of fat body precursors necessary for adult adipogenesis in Drosophila

Regulation of Hepatocyte Growth Factor Expression by NF-κB and PPARγ in Adipose Tissue.

Fibroblast Growth Factor 21 Suppresses Adipogenesis in Pig Intramuscular Fat Cells

Downstream Signaling Pathways in Mouse Adipose Tissues Following Acute in Vivo Administration of Fibroblast Growth Factor 21.

Adipocyte Subpopulations Mediate Growth Hormone-induced Lipolysis and Glucose Tolerance in Male Mice